Mebeverine Hydrochloride Noumed Life Sciences (Mebeverine Hydrochloride)

The drug works by directly relaxing the smooth muscle of the gastrointestinal tract. It inhibits calcium entry into muscle cells and modulates muscarinic receptors, which together diminish muscle hyper‑responsiveness, reduce spasm, and alleviate pain without markedly altering normal motility.

The appropriate dose of Mebeverine Hydrochloride is determined by the prescribing healthcare professional based on the individual’s condition, severity of symptoms, and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Mebeverine Hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mebeverine is a direct smooth‑muscle relaxant that does not possess significant anticholinergic activity, unlike some older antispasmodics such as hyoscine. This profile often results in fewer dry‑mouth or blurred‑vision side effects, making it a preferred option for patients who need symptom relief with a lower risk of anticholinergic burden.

Store the product at ambient temperature, preferably below 25 °C, in the original packaging. Keep it away from moisture, direct sunlight, and extreme heat to maintain its stability and potency throughout its shelf life.

Mebeverine Hydrochloride is taken orally, usually with a glass of water. The exact timing (e.g., before meals or at bedtime) and frequency are determined by the prescribing clinician based on the patient’s therapeutic needs.

Serious adverse reactions, although rare, can include severe allergic responses such as rash, swelling, or anaphylaxis, as well as significant hypotension, tachycardia, hepatic dysfunction, and neutropenia. Patients should seek immediate medical attention if any of these symptoms develop.

Individuals with known hypersensitivity to mebeverine or any of its excipients should avoid the medication. Caution is also advised for patients with severe hepatic or renal impairment, and it is generally contraindicated in those taking medications that may cause dangerous additive effects without close monitoring.